Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Healthcare Provider (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Type (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedure (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including Kits), and Services], and Disease Indication (Early Gastric Cancer and Gastric Cancer Advanced Types)
The gastric cancer diagnostic procedure market is expected to grow from US$ 1307.96 million in 2022 to US$ 1912.03 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2022 to 2028.
The presence of a huge patient population with gastrointestinal tumors, lymphoma, and adenocarcinoma, the increase in the geriatric population, and the rise in alcohol consumption and smoking are among the factors contributing to the growing gastric cancer diagnostic procedure market size. However, the shortage of medical laboratory professionals hinders the growth of the gastric cancer diagnostic procedures market.
Gastric cancer is a type of malignant cancer that forms the stomach's inner lining. Risk factors such as age, diet, and stomach diseases can lead to the development of gastric cancer. Symptoms of gastric cancer include indigestion, heartburn, bloating, and stomach discomfort or pain.
Many market players and research institutes operating in the gastric cancer diagnostics market are developing advanced products to expand their product portfolios and increase their market shares. They invest significant amounts in R&D to develop advanced products. A few of the recent developments related to gastric cancer diagnostic platforms are mentioned below:
Ibex Medical Analytics, a pioneer in AI-powered cancer diagnostics, developed the world’s first artificial intelligence (AI) platform to detect cancer. Its AI algorithms analyze images of biopsies and can pinpoint their location and grade the tumor. These results help pathologists diagnose gastric cancer accurately. In June 2021, the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to Ibex’s Galen platform, which will expedite the clinical review and regulatory approval of its platform. Galen Gastric is an integrated diagnostics and quality control solution that supports pathologists in the detection of gastric cancer, dysplasia, H. pylori, and other important clinical findings.
In November 2019, AI Medical Service Inc., one of the world's first real-time endoscopic AI developers, secured Breakthrough Device Designation by the US FDA for its AI programs that analyze endoscopy images for potential diagnosis of gastric cancer. In February 2022, Mayo Clinic researchers used AI and informatics to discover a 32-gene signature that is a prognostic and predictive biomarker for patients suffering from gastric cancer. The study was published in the edition of Nature Communications.Thus, such development of AI-based gastric cancer diagnostics are likely to introduce new trends in the gastric cancer diagnostic procedure market during the forecast period.
The COVID-19 pandemic altered economic conditions and social behaviors in countries. Containment measures enacted by governments to mitigate the spread of disease changed the pattern of healthcare service delivery in the US. According to the Department of Emergency Medicine, in many cities across the country, emergency department (ED) visits decreased by ~40% in 2020. Moreover, outpatient appointments and elective treatments were postponed or replaced by telemedicine practices.
In November 2021, Pfizer Inc. announced the investigational COVID-19 oral antiviral candidate, PAXLOVID. Based on an interim analysis of the Phase 2/3 Evaluation of Protease Inhibition for COVID-19 in high-risk patients (EPIC-HR) and a randomized, double-blind study of non-hospitalized adult patients with COVID-19, who were at a high risk of progressing to severe illness, it was observed that the PAXLOVID vaccine reportedly reduced hospitalization and death. There were supply constraints related to vaccine production in the initial months of 2021. However, setting up new plants and promoting technological shifts supported the production of booster doses in the US and Canada, along with their administration plans.
Furthermore, In March 2021, Eurofins' Clinical Enterprise, Inc. obtained an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a direct-to-consumer (DTC) version of its EmpowerDX COVID-19 Home Collection Kit. The Eurofins at-home COVID-19 nasal PCR kit is one of the first over-the-counter SARS-CoV-2 at-home test kits. Similarly, in March 2020, the US FDA issued Emergency Use Authorization (EUA) to Abbott for its fastest available molecular point-of-care test to detect novel coronavirus (COVID-19), which delivers positive results in approximately 5 minutes and negative results in around 13 minutes. Thus, the rise in product launches is supporting the gastric cancer diagnostic procedure market.
Healthcare Providers-Based Insights
Based on healthcare providers, the global gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, others. In 2022, the hospitals segment held the largest share of the market. The cancer research institutes segment is expected to grow at the fastest rate during the coming years.
Symptom Type-Based Insights
Based on symptom type, the gastric cancer diagnostic procedure market is bifurcated into symptomatic and asymptomatic. In 2022, the asymptomatic segment held a larger share of the market. Moreover, the symptomatic segment is estimated to grow at significant CAGR during the forecast period.
Body Fluid-Based Insights
The gastric cancer diagnostic procedure market, by body fluid, is segmented into blood, urine, saliva, stomach wash/gastric juice, tissue, and others. In 2022, the blood segment held the largest share of the market. Moreover, the tissue segment is expected to grow at the fastest rate during the coming years.
Procedures-Based Insights
The gastric cancer diagnostic procedure market, based on procedures, is segmented into endoscopic procedures, biopsy and tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics and immunoassays, and others. In 2022, the imaging tests segment held the largest share of the market. The endoscopic segment is expected to grow at the fastest rate during the coming years.
A few of the major primary and secondary sources referred to while preparing the report on the gastric cancer diagnostic procedure market are the World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine, among others.
The presence of a huge patient population with gastrointestinal tumors, lymphoma, and adenocarcinoma, the increase in the geriatric population, and the rise in alcohol consumption and smoking are among the factors contributing to the growing gastric cancer diagnostic procedure market size. However, the shortage of medical laboratory professionals hinders the growth of the gastric cancer diagnostic procedures market.
Gastric cancer is a type of malignant cancer that forms the stomach's inner lining. Risk factors such as age, diet, and stomach diseases can lead to the development of gastric cancer. Symptoms of gastric cancer include indigestion, heartburn, bloating, and stomach discomfort or pain.
Many market players and research institutes operating in the gastric cancer diagnostics market are developing advanced products to expand their product portfolios and increase their market shares. They invest significant amounts in R&D to develop advanced products. A few of the recent developments related to gastric cancer diagnostic platforms are mentioned below:
Ibex Medical Analytics, a pioneer in AI-powered cancer diagnostics, developed the world’s first artificial intelligence (AI) platform to detect cancer. Its AI algorithms analyze images of biopsies and can pinpoint their location and grade the tumor. These results help pathologists diagnose gastric cancer accurately. In June 2021, the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to Ibex’s Galen platform, which will expedite the clinical review and regulatory approval of its platform. Galen Gastric is an integrated diagnostics and quality control solution that supports pathologists in the detection of gastric cancer, dysplasia, H. pylori, and other important clinical findings.
In November 2019, AI Medical Service Inc., one of the world's first real-time endoscopic AI developers, secured Breakthrough Device Designation by the US FDA for its AI programs that analyze endoscopy images for potential diagnosis of gastric cancer. In February 2022, Mayo Clinic researchers used AI and informatics to discover a 32-gene signature that is a prognostic and predictive biomarker for patients suffering from gastric cancer. The study was published in the edition of Nature Communications.Thus, such development of AI-based gastric cancer diagnostics are likely to introduce new trends in the gastric cancer diagnostic procedure market during the forecast period.
The COVID-19 pandemic altered economic conditions and social behaviors in countries. Containment measures enacted by governments to mitigate the spread of disease changed the pattern of healthcare service delivery in the US. According to the Department of Emergency Medicine, in many cities across the country, emergency department (ED) visits decreased by ~40% in 2020. Moreover, outpatient appointments and elective treatments were postponed or replaced by telemedicine practices.
In November 2021, Pfizer Inc. announced the investigational COVID-19 oral antiviral candidate, PAXLOVID. Based on an interim analysis of the Phase 2/3 Evaluation of Protease Inhibition for COVID-19 in high-risk patients (EPIC-HR) and a randomized, double-blind study of non-hospitalized adult patients with COVID-19, who were at a high risk of progressing to severe illness, it was observed that the PAXLOVID vaccine reportedly reduced hospitalization and death. There were supply constraints related to vaccine production in the initial months of 2021. However, setting up new plants and promoting technological shifts supported the production of booster doses in the US and Canada, along with their administration plans.
Furthermore, In March 2021, Eurofins' Clinical Enterprise, Inc. obtained an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a direct-to-consumer (DTC) version of its EmpowerDX COVID-19 Home Collection Kit. The Eurofins at-home COVID-19 nasal PCR kit is one of the first over-the-counter SARS-CoV-2 at-home test kits. Similarly, in March 2020, the US FDA issued Emergency Use Authorization (EUA) to Abbott for its fastest available molecular point-of-care test to detect novel coronavirus (COVID-19), which delivers positive results in approximately 5 minutes and negative results in around 13 minutes. Thus, the rise in product launches is supporting the gastric cancer diagnostic procedure market.
Healthcare Providers-Based Insights
Based on healthcare providers, the global gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, others. In 2022, the hospitals segment held the largest share of the market. The cancer research institutes segment is expected to grow at the fastest rate during the coming years.
Symptom Type-Based Insights
Based on symptom type, the gastric cancer diagnostic procedure market is bifurcated into symptomatic and asymptomatic. In 2022, the asymptomatic segment held a larger share of the market. Moreover, the symptomatic segment is estimated to grow at significant CAGR during the forecast period.
Body Fluid-Based Insights
The gastric cancer diagnostic procedure market, by body fluid, is segmented into blood, urine, saliva, stomach wash/gastric juice, tissue, and others. In 2022, the blood segment held the largest share of the market. Moreover, the tissue segment is expected to grow at the fastest rate during the coming years.
Procedures-Based Insights
The gastric cancer diagnostic procedure market, based on procedures, is segmented into endoscopic procedures, biopsy and tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics and immunoassays, and others. In 2022, the imaging tests segment held the largest share of the market. The endoscopic segment is expected to grow at the fastest rate during the coming years.
A few of the major primary and secondary sources referred to while preparing the report on the gastric cancer diagnostic procedure market are the World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine, among others.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Gastric cancer diagnostic procedure Market – by Healthcare Providers
1.3.2 Global Gastric Cancer Diagnostic Procedure Market – By Symptom Types
1.3.3 Global Gastric Cancer Diagnostic Procedure Market – By Body Fluid
1.3.4 Global Gastric Cancer Diagnostic Procedure Market – By Procedures
1.3.5 Global Gastric Cancer Diagnostic Procedure Market – By Offerings
1.3.6 Global Gastric Cancer Diagnostic Procedure Market – By Disease Indication
1.3.7 Global Gastric cancer diagnostic procedure Market – by Geography
2. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal Diseases
5.1.2 Surging Cases of Helicobacter Pylori Infection
5.2 Market Restraints
5.2.1 Shortage of Medical Laboratory Professionals
5.3 Market Opportunities
5.3.1 Rising Awareness of Gastric Cancer
5.4 Future Trends
5.4.1 Development of AI-Based Gastric Cancer Diagnostic Platform
5.5 Impact Analysis
6. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – GLOBAL ANALYSIS
6.1 Global Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis
6.2 Global Gastric Cancer Diagnostic Procedure Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Global Gastric Cancer Diagnostic Procedure Market – Market Potential Analysis, by Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
6.7.1 F. Hoffmann-La Roche Ltd
6.7.2 Thermo Fisher Scientific Inc
7. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY HEALTHCARE PROVIDERS
7.1 Overview
7.2 Diagnostic Laboratories
7.2.1 Overview
7.2.2 Diagnostic Laboratories: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.3 Hospitals
7.3.1 Overview
7.3.2 Hospitals: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer Research Institutes
7.4.1 Overview
7.4.2 Cancer Research Institutes: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Oncology Specialty Clinics
7.5.1 Overview
7.5.2 Oncology Specialty Clinics: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
8. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET ANALYSIS AND FORECASTS TO 2028 – BY SYMPTOM TYPES
8.1 Overview
8.2 Symptomatic
8.2.1 Overview
8.2.2 Symptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
8.3 Asymptomatic
8.3.1 Overview
8.3.2 Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY BODY FLUID
9.1 Overview
9.2 Blood
9.2.1 Overview
9.2.2 Blood: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.3 Urine
9.3.1 Overview
9.3.2 Urine: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Saliva
9.4.1 Overview
9.4.2 Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Stomach Wash/Gastric Juice
9.5.1 Overview
9.5.2 Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Tissue
9.6.1 Overview
9.6.2 Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
10. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY PROCEDURE
10.1 Overview
10.2 Endoscopic Procedure
10.2.1 Overview
10.2.2 Endoscopic Procedure: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.3 Biopsy and Tissue Tests
10.3.1 Overview
10.3.2 Biopsy and Tissue Tests: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.4 Lab Tests
10.4.1 Overview
10.4.2 Lab Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.5 In-Vitro Diagnostic Tests
10.5.1 Overview
10.5.2 In-Vitro Diagnostic Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Imaging Tests
10.6.1 Overview
10.6.2 Imaging Tests: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Molecular Diagnostics
10.7.1 Overview
10.7.2 Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Multiplexing Molecular Diagnostics and Immunoassay
10.8.1 Overview
10.8.2 Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY OFFERINGS
11.1 Overview
11.2 Instruments
11.2.1 Overview
11.2.2 Instruments: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.3 Reagents and Consumables
11.3.1 Overview
11.3.2 Reagents and Consumables: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Services
11.4.1 Overview
11.4.2 Services: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE ANALYSIS – BY DISEASE INDICATION
12.1 Overview
12.2 Early Gastric Cancer
12.2.1 Overview
12.2.2 Early Gastric Cancer: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12.3 Gastric Cancer Advanced Types
12.3.1 Overview
12.3.2 Gastric Cancer Advanced Types: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
13. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – GEOGRAPHIC ANALYSIS
13.1 North America: Gastric Cancer Diagnostic Procedure Market
13.1.1 Overview
13.1.2 North America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.3 North America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.3.1 North America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.3.2 North America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.3.3 North America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.3.4 North America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.4 North America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.5 North America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.6 North America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.6.1 North America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.6.2 North America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.6.3 North America: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.6.4 North America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.6.5 North America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.7 North America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.8 North America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.9 North America: Gastric Cancer Diagnostic Procedure Market, by Country
13.1.9.1 US: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.1.1 Overview
13.1.9.1.2 United States: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.1.3 United States: Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.9.1.3.1 United States: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.9.1.3.2 United States: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.9.1.3.3 United States: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.9.1.3.4 United States: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.9.1.4 United States: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.9.1.5 United States: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.9.1.6 United States: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.9.1.6.1 United States: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.9.1.6.2 United States: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.9.1.6.3 United States: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.9.1.6.4 United States: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.9.1.6.5 United States: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.9.1.7 United States: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.9.1.8 United States: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.9.2 Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.2.1 Overview
13.1.9.2.2 Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.2.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.9.2.3.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.9.2.3.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.9.2.3.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.9.2.3.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.9.2.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.9.2.5 Canada: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.9.2.6 Canada: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.9.2.6.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.9.2.6.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.9.2.6.3 Canada: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.9.2.6.4 Canada Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.9.2.6.5 Canada Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.9.2.7 Canada Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.9.2.8 Canada Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.9.3 Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.3.1 Overview
13.1.9.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.9.3.3.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.9.3.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.9.3.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.9.3.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.9.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.9.3.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.9.3.6 Mexico: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.9.3.6.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.9.3.6.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.9.3.6.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.9.3.6.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.9.3.6.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.9.3.7 Mexico: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.9.3.8 Mexico: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2 Europe: Gastric Cancer Diagnostic Procedure Market
13.2.1 Overview
13.2.2 Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.3 Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.3.1 Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.3.2 Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.3.3 Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.3.4 Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.4 Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.5 Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.6 Europe Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.6.1 Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.6.2 Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.6.3 Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.6.4 Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.6.5 Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.7 Europe Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.8 Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9 Europe: Gastric Cancer Diagnostic Procedure Market, by Country
13.2.9.1 Germany: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.1 Overview
13.2.9.1.2 Germany Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.3 Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.1.3.1 Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.1.3.2 Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.1.3.3 Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.1.3.4 Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.1.4 Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.1.5 Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.1.6 Germany Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.1.6.1 Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.1.6.2 Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.1.6.3 Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.1.6.4 Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.1.6.5 Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.1.7 Germany Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.1.8 Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.2 France: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.1 Overview
13.2.9.2.2 France: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.3 France: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million)
13.2.9.2.3.1 France: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.2.3.2 France: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.2.3.3 France: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.2.3.4 France: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.2.4 France: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.2.5 France: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.2.6 France: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.2.6.1 France: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.2.6.2 France: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.2.6.3 France: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.2.6.4 France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.2.6.5 France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.2.7 France Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.2.8 France Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.3 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.1 Overview
13.2.9.3.2 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.3.3.1 UK: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.3.3.2 UK: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.3.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.3.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.3.5 UK: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.3.6 UK: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.3.6.1 UK: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.3.6.2 UK: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.3.6.3 UK: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.3.6.4 UK: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.3.6.5 UK: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.3.7 UK: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.3.8 UK: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.4 Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.1 Overview
13.2.9.4.2 Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.4.3.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.4.3.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.4.3.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.4.3.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.4.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.4.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.4.6 Italy: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.4.6.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.4.6.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.4.6.3 Italy: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.4.6.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.4.6.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.4.7 Italy: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.4.8 Italy: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.5 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.1 Overview
13.2.9.5.2 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.5.3.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.5.3.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.5.3.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.5.3.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.5.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.5.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.5.6 Spain: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.5.6.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.5.6.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.5.6.3 Spain: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.5.6.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.5.6.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.5.7 Spain: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.5.8 Spain: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.1 Overview
13.2.9.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.6.3.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.6.3.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.6.3.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.6.3.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.6.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.6.6.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.6.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.6.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.6.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.6.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.6.7 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.6.8 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market
13.3.1 Overview
13.3.2 Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.3.3.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.3.3.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.3.3.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.3.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.3.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.3.6 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.3.6.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.3.6.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.3.6.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.3.6.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.3.6.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.3.7 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.3.8 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.3.9 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Country
13.3.9.1 China: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.1.1 Overview
13.3.9.1.2 China Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.1.3 China Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.3.9.1.3.1 China Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.3.9.1.3.2 China Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.3.9.1.3.3 China Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.3.9.1.3.4 China Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.3.9.1.4 China Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.3.9.1.5 China Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.3.9.1.6 China Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.3.9.1.6.1 China Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.3.9.1.6.2 China Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.3.9.1.6.3 China Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.3.9.1.6.4 China Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.3.9.1.6.5 China Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.3.9.1.7 China Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.3.9.1.8 China Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.3.9.2 Japan: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.2.1 Overview
13.3.9.2.2 Japan: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.2.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million)
13.3.9.2.3.1 Japan: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.3.9.2.3.2 Japan: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.3.9.2.3.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Cancer Rese
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Gastric cancer diagnostic procedure Market – by Healthcare Providers
1.3.2 Global Gastric Cancer Diagnostic Procedure Market – By Symptom Types
1.3.3 Global Gastric Cancer Diagnostic Procedure Market – By Body Fluid
1.3.4 Global Gastric Cancer Diagnostic Procedure Market – By Procedures
1.3.5 Global Gastric Cancer Diagnostic Procedure Market – By Offerings
1.3.6 Global Gastric Cancer Diagnostic Procedure Market – By Disease Indication
1.3.7 Global Gastric cancer diagnostic procedure Market – by Geography
2. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal Diseases
5.1.2 Surging Cases of Helicobacter Pylori Infection
5.2 Market Restraints
5.2.1 Shortage of Medical Laboratory Professionals
5.3 Market Opportunities
5.3.1 Rising Awareness of Gastric Cancer
5.4 Future Trends
5.4.1 Development of AI-Based Gastric Cancer Diagnostic Platform
5.5 Impact Analysis
6. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – GLOBAL ANALYSIS
6.1 Global Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis
6.2 Global Gastric Cancer Diagnostic Procedure Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Global Gastric Cancer Diagnostic Procedure Market – Market Potential Analysis, by Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
6.7.1 F. Hoffmann-La Roche Ltd
6.7.2 Thermo Fisher Scientific Inc
7. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY HEALTHCARE PROVIDERS
7.1 Overview
7.2 Diagnostic Laboratories
7.2.1 Overview
7.2.2 Diagnostic Laboratories: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.3 Hospitals
7.3.1 Overview
7.3.2 Hospitals: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer Research Institutes
7.4.1 Overview
7.4.2 Cancer Research Institutes: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Oncology Specialty Clinics
7.5.1 Overview
7.5.2 Oncology Specialty Clinics: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
8. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET ANALYSIS AND FORECASTS TO 2028 – BY SYMPTOM TYPES
8.1 Overview
8.2 Symptomatic
8.2.1 Overview
8.2.2 Symptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
8.3 Asymptomatic
8.3.1 Overview
8.3.2 Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY BODY FLUID
9.1 Overview
9.2 Blood
9.2.1 Overview
9.2.2 Blood: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.3 Urine
9.3.1 Overview
9.3.2 Urine: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Saliva
9.4.1 Overview
9.4.2 Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Stomach Wash/Gastric Juice
9.5.1 Overview
9.5.2 Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Tissue
9.6.1 Overview
9.6.2 Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
10. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY PROCEDURE
10.1 Overview
10.2 Endoscopic Procedure
10.2.1 Overview
10.2.2 Endoscopic Procedure: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.3 Biopsy and Tissue Tests
10.3.1 Overview
10.3.2 Biopsy and Tissue Tests: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.4 Lab Tests
10.4.1 Overview
10.4.2 Lab Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.5 In-Vitro Diagnostic Tests
10.5.1 Overview
10.5.2 In-Vitro Diagnostic Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Imaging Tests
10.6.1 Overview
10.6.2 Imaging Tests: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Molecular Diagnostics
10.7.1 Overview
10.7.2 Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Multiplexing Molecular Diagnostics and Immunoassay
10.8.1 Overview
10.8.2 Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY OFFERINGS
11.1 Overview
11.2 Instruments
11.2.1 Overview
11.2.2 Instruments: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.3 Reagents and Consumables
11.3.1 Overview
11.3.2 Reagents and Consumables: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Services
11.4.1 Overview
11.4.2 Services: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12. GLOBAL GASTRIC CANCER DIAGNOSTIC PROCEDURE ANALYSIS – BY DISEASE INDICATION
12.1 Overview
12.2 Early Gastric Cancer
12.2.1 Overview
12.2.2 Early Gastric Cancer: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12.3 Gastric Cancer Advanced Types
12.3.1 Overview
12.3.2 Gastric Cancer Advanced Types: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
13. GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – GEOGRAPHIC ANALYSIS
13.1 North America: Gastric Cancer Diagnostic Procedure Market
13.1.1 Overview
13.1.2 North America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.3 North America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.3.1 North America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.3.2 North America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.3.3 North America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.3.4 North America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.4 North America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.5 North America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.6 North America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.6.1 North America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.6.2 North America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.6.3 North America: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.6.4 North America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.6.5 North America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.7 North America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.8 North America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.9 North America: Gastric Cancer Diagnostic Procedure Market, by Country
13.1.9.1 US: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.1.1 Overview
13.1.9.1.2 United States: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.1.3 United States: Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.9.1.3.1 United States: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.9.1.3.2 United States: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.9.1.3.3 United States: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.9.1.3.4 United States: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.9.1.4 United States: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.9.1.5 United States: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.9.1.6 United States: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.9.1.6.1 United States: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.9.1.6.2 United States: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.9.1.6.3 United States: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.9.1.6.4 United States: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.9.1.6.5 United States: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.9.1.7 United States: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.9.1.8 United States: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.9.2 Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.2.1 Overview
13.1.9.2.2 Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.2.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.9.2.3.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.9.2.3.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.9.2.3.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.9.2.3.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.9.2.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.9.2.5 Canada: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.9.2.6 Canada: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.9.2.6.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.9.2.6.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.9.2.6.3 Canada: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.9.2.6.4 Canada Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.9.2.6.5 Canada Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.9.2.7 Canada Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.9.2.8 Canada Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.9.3 Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.3.1 Overview
13.1.9.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.9.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.9.3.3.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.9.3.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.9.3.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.9.3.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.9.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.9.3.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.9.3.6 Mexico: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.9.3.6.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.9.3.6.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.9.3.6.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.9.3.6.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.9.3.6.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.9.3.7 Mexico: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.9.3.8 Mexico: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2 Europe: Gastric Cancer Diagnostic Procedure Market
13.2.1 Overview
13.2.2 Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.3 Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.3.1 Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.3.2 Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.3.3 Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.3.4 Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.4 Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.5 Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.6 Europe Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.6.1 Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.6.2 Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.6.3 Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.6.4 Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.6.5 Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.7 Europe Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.8 Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9 Europe: Gastric Cancer Diagnostic Procedure Market, by Country
13.2.9.1 Germany: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.1 Overview
13.2.9.1.2 Germany Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.3 Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.1.3.1 Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.1.3.2 Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.1.3.3 Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.1.3.4 Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.1.4 Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.1.5 Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.1.6 Germany Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.1.6.1 Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.1.6.2 Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.1.6.3 Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.1.6.4 Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.1.6.5 Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.1.7 Germany Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.1.8 Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.2 France: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.1 Overview
13.2.9.2.2 France: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.3 France: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million)
13.2.9.2.3.1 France: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.2.3.2 France: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.2.3.3 France: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.2.3.4 France: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.2.4 France: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.2.5 France: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.2.6 France: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.2.6.1 France: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.2.6.2 France: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.2.6.3 France: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.2.6.4 France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.2.6.5 France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.2.7 France Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.2.8 France Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.3 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.1 Overview
13.2.9.3.2 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.3.3.1 UK: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.3.3.2 UK: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.3.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.3.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.3.5 UK: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.3.6 UK: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.3.6.1 UK: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.3.6.2 UK: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.3.6.3 UK: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.3.6.4 UK: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.3.6.5 UK: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.3.7 UK: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.3.8 UK: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.4 Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.1 Overview
13.2.9.4.2 Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.4.3.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.4.3.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.4.3.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.4.3.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.4.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.4.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.4.6 Italy: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.4.6.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.4.6.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.4.6.3 Italy: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.4.6.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.4.6.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.4.7 Italy: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.4.8 Italy: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.5 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.1 Overview
13.2.9.5.2 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.5.3.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.5.3.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.5.3.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.5.3.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.5.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.5.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.5.6 Spain: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.5.6.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.5.6.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.5.6.3 Spain: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.5.6.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.5.6.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.5.7 Spain: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.5.8 Spain: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.2.9.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.1 Overview
13.2.9.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.2.9.6.3.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.2.9.6.3.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.2.9.6.3.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.2.9.6.3.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.2.9.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.2.9.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.2.9.6.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.2.9.6.6.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.2.9.6.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.2.9.6.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.2.9.6.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.2.9.6.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.2.9.6.7 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.2.9.6.8 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market
13.3.1 Overview
13.3.2 Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.3.3.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.3.3.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.3.3.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.3.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.3.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.3.6 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.3.6.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.3.6.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.3.6.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.3.6.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.3.6.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.3.7 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.3.8 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.3.9 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Country
13.3.9.1 China: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.1.1 Overview
13.3.9.1.2 China Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.1.3 China Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.3.9.1.3.1 China Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.3.9.1.3.2 China Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.3.9.1.3.3 China Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.3.9.1.3.4 China Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.3.9.1.4 China Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.3.9.1.5 China Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.3.9.1.6 China Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.3.9.1.6.1 China Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.3.9.1.6.2 China Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.3.9.1.6.3 China Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.3.9.1.6.4 China Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.3.9.1.6.5 China Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.3.9.1.7 China Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.3.9.1.8 China Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.3.9.2 Japan: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.2.1 Overview
13.3.9.2.2 Japan: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.3.9.2.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million)
13.3.9.2.3.1 Japan: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.3.9.2.3.2 Japan: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.3.9.2.3.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Cancer Rese
